口服非他汀类药物和苯培多酸治疗ASCVD风险:DELPHI声明

Cardiology and cardiovascular medicine Pub Date : 2023-01-01 DOI:10.26502/fccm.92920337

J. Sawhney, S. Ray, Prakash C Hazra, S. Sathe, B. Srinivas, V. Pathak, J. Shah, Kamal Sharma, Ashutosh Kakkad, K. K.

{"title":"口服非他汀类药物和苯培多酸治疗ASCVD风险:DELPHI声明","authors":"J. Sawhney, S. Ray, Prakash C Hazra, S. Sathe, B. Srinivas, V. Pathak, J. Shah, Kamal Sharma, Ashutosh Kakkad, K. K.","doi":"10.26502/fccm.92920337","DOIUrl":null,"url":null,"abstract":"Background: In Asian countries, the high endemicity of Coronary Artery Disease (CAD) has been associated with an increase in premature deaths requiring a multi-interventional or multidisciplinary approach to control the cardiovascular risk traits associated with most of these cases. Objective: ESC recommendations on lipid goals of ≤55 mg/dl in Atherosclerotic cardiovascular disease (ASCVD)","PeriodicalId":72523,"journal":{"name":"Cardiology and cardiovascular medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treat to Target ASCVD Risk with Oral Non-statins and Bempedoic Acid: DELPHI Statement\",\"authors\":\"J. Sawhney, S. Ray, Prakash C Hazra, S. Sathe, B. Srinivas, V. Pathak, J. Shah, Kamal Sharma, Ashutosh Kakkad, K. K.\",\"doi\":\"10.26502/fccm.92920337\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: In Asian countries, the high endemicity of Coronary Artery Disease (CAD) has been associated with an increase in premature deaths requiring a multi-interventional or multidisciplinary approach to control the cardiovascular risk traits associated with most of these cases. Objective: ESC recommendations on lipid goals of ≤55 mg/dl in Atherosclerotic cardiovascular disease (ASCVD)\",\"PeriodicalId\":72523,\"journal\":{\"name\":\"Cardiology and cardiovascular medicine\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiology and cardiovascular medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26502/fccm.92920337\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiology and cardiovascular medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26502/fccm.92920337","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

背景:在亚洲国家，冠状动脉疾病(CAD)的高流行率与过早死亡的增加有关，需要多介入或多学科的方法来控制与大多数这些病例相关的心血管风险特征。目的:ESC推荐动脉粥样硬化性心血管疾病(ASCVD)患者血脂目标≤55 mg/dl

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Treat to Target ASCVD Risk with Oral Non-statins and Bempedoic Acid: DELPHI Statement

Background: In Asian countries, the high endemicity of Coronary Artery Disease (CAD) has been associated with an increase in premature deaths requiring a multi-interventional or multidisciplinary approach to control the cardiovascular risk traits associated with most of these cases. Objective: ESC recommendations on lipid goals of ≤55 mg/dl in Atherosclerotic cardiovascular disease (ASCVD)

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cardiology and cardiovascular medicine

自引率

0.00%

发文量